Concepedia
Statistics
Publications
6
Citations
415
H-Index
Active since
1999
Affiliations
The University of Texas MD Anderson Cancer Center(Current)
Fred Hutch Cancer Center
University of Washington
Farhad Ravandi is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and chemotherapy.
Publications per year
1999–2025
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
Roland B. Walter, Megan Othus, Alan K. Burnett et al. · Leukemia · 2014 · 174 citations · Full text
Medicine, Oncology, Chemotherapy +9
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
Marina Konopleva, Peter F. Thall, Cecilia Arana Yi et al. · Haematologica · 2015 · 122 citations · Full text
Medicine, Oncology, Pharmacology +16
Chronic myelogenous leukaemia with p185<i><sup>BCR/ABL</sup></i> expression: characteristics and clinical significance
Farhad Ravandi, Jörge E. Cortes, Maher Albitar et al. · British Journal of Haematology · 1999 · 63 citations
Medicine, Hematology, Oncology +17
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia
J. E. Lancet, G.J. Roboz, Larry D. Cripe et al. · Haematologica · 2014 · 28 citations · Full text
Medicine, Oncology, Pharmacology +17
Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms
Jayastu Senapati, Sanam Loghavi, Guillermo Garcia‐Manero et al. · Haematologica · 2024 · 17 citations · Full text
Medicine, Hematology, Oncology +15
1–5 of 6